dc.creatorSasono, Wimbo
dc.creatorNurwasis
dc.creatorAryati
dc.creatorYustiarini, Ima
dc.creatorSuhendro, Gatut
dc.date2022-10-01
dc.date.accessioned2022-10-28T12:08:08Z
dc.date.available2022-10-28T12:08:08Z
dc.identifierhttp://saber.ucv.ve/ojs/index.php/rev_gmc/article/view/24534
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4956038
dc.descriptionDiabetic macular edema (DME), a further complication of diabetic retinopathy, is a clinical manifestation of a breakdown of the blood-retinal barrier in the form of thickening of the retinal fovea, exudates formation on the retina, and cystoid macular edema. The breakdown mechanism is based on the process of unstabilized vascular integrity, angiogenesis, and inflammation. A combination of these mechanisms, among others, is well known to be implemented by VEGF.es-ES
dc.formatapplication/pdf
dc.languagespa
dc.publisherAcademia Nacional de Medicina venezolana.es-ES
dc.relationhttp://saber.ucv.ve/ojs/index.php/rev_gmc/article/view/24534/144814490760
dc.rightsDerechos de autor 2022 Gaceta Médica de Caracases-ES
dc.rightshttps://creativecommons.org/licenses/by-nc/4.0es-ES
dc.sourceGaceta Médica de Caracas; Vol. 130 Núm. 3 (2022)es-ES
dc.source2739-0012
dc.source0367-4762
dc.subjectMicro RNAes-ES
dc.subjectdiabetic macular edemaes-ES
dc.subjectretinaes-ES
dc.titleThe role of micro-RNA (miRNA) 126 on diabetic macular edema. Literature review.es-ES
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion


Este ítem pertenece a la siguiente institución